ImmunityBio Inc. (IBRX)
NASDAQ: IBRX
· Real-Time Price · USD
2.54
-0.17 (-6.27%)
At close: Aug 15, 2025, 3:59 PM
2.56
0.59%
After-hours: Aug 15, 2025, 07:58 PM EDT
ImmunityBio Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 56.6M | 31.22M | 14.74M | 7.33M | 1.31M | 302K | 622K | 556K | 592K | 586K | 240K | 557K | 505K | 809K | 934K | 397K | 482K | 579K |
Cost of Revenue | 194K | 58K | 4.55M | 9.12M | 13.7M | 20.02M | 21.75M | 24.06M | 25.45M | 25.06M | 24.19M | 17.31M | 11.34M | 5.41M | n/a | n/a | n/a | n/a |
Gross Profit | 56.41M | 31.16M | 10.19M | -1.79M | -12.4M | -19.72M | -21.12M | -23.5M | -24.86M | -24.48M | -23.95M | -16.76M | -10.83M | -4.6M | 934K | 397K | 482K | 579K |
Operating Income | -285.37M | -313.42M | -344.18M | -359.29M | -359.17M | -344.98M | -361.36M | -361.76M | -372.43M | -366.91M | -351.3M | -345.67M | -333.7M | -339.99M | -330.28M | -318.39M | -305.43M | -270.44M |
Interest Income | 3.37M | 3.38M | 2.4M | 3.48M | 3.45M | 3.21M | 3.33M | 2M | 1.64M | 1.7M | 2.71M | 2.48M | 2.33M | 1.79M | 836K | 1.08M | 1.51M | 1.74M |
Pretax Income | -366.88M | -409.16M | -413.64M | -587.92M | -597.75M | -601.38M | -583.83M | -458.67M | -474.25M | -430.87M | -417.29M | -400.55M | -377.81M | -372.36M | -349.84M | -327.07M | -306.51M | -269.1M |
Net Income | -367.09M | -409.1M | -413.56M | -587.79M | -597.65M | -600.96M | -618.01M | -492.95M | -508.31M | -465.01M | -416.68M | -399.61M | -376.3M | -370M | -346.79M | -323.3M | -301.28M | -264.43M |
Selling & General & Admin | 151.96M | 158.88M | 164.73M | 152.04M | 147.94M | 130.71M | 125.56M | 122.72M | 110.22M | 94.78M | 102.71M | 104.4M | 114.72M | 130.59M | 135.26M | 131.23M | 121.2M | 107.1M |
Research & Development | 186.88M | 182.77M | 189.64M | 205.46M | 203.41M | 205.45M | 231.87M | 238.91M | 262.12M | 272.04M | 248.15M | 241.82M | 219.49M | 210.21M | 195.96M | 187.56M | 174.06M | 153.26M |
Other Expenses | 2.94M | 2.94M | -20K | -20K | 6.45M | -346K | -1.4M | -2.33M | -8.79M | -1.81M | -736K | 128K | 84K | 176K | 193K | 469K | 591K | 395K |
Operating Expenses | 341.77M | 344.58M | 354.37M | 357.5M | 351.36M | 336.16M | 357.42M | 361.64M | 372.34M | 366.81M | 350.86M | 346.23M | 334.21M | 340.8M | 331.21M | 318.79M | 295.25M | 260.36M |
Interest Expense | 135.57M | 145.71M | 154.33M | 148.88M | 143.65M | 136.87M | 129.18M | 125.61M | 107.36M | 84.82M | 63.52M | 39.44M | 26.29M | 20.17M | 14.85M | 13.2M | 11.81M | 10.35M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 341.97M | 344.64M | 358.93M | 366.62M | 360.48M | 345.28M | 361.99M | 361.64M | 372.34M | 366.81M | 350.86M | 346.23M | 334.21M | 340.8M | 331.21M | 318.79M | 295.25M | 260.36M |
Income Tax Expense | 286K | 17K | -4K | -61K | -4.65M | -4.65M | 29.95M | 30.03M | 34.39M | 34.39M | -361K | -394K | -971K | -969K | -791K | -1M | -1.9M | -1.86M |
Shares Outstanding (Basic) | 888.22M | 853.16M | 697.31M | 695.89M | 686.94M | 672.83M | 670.87M | 498.38M | 437.46M | 428.38M | 403.64M | 400.06M | 397.99M | 397.88M | 397.12M | 391.85M | 384.82M | 382.74M |
Shares Outstanding (Diluted) | 888.22M | 853.16M | 700.44M | 697.96M | 686.94M | 672.83M | 670.87M | 498.38M | 437.46M | 428.38M | 403.64M | 400.06M | 397.99M | 397.88M | 397.12M | 391.85M | 384.82M | 382.74M |
EPS (Basic) | -0.49 | -0.59 | -0.64 | -0.89 | -0.94 | -1.06 | -1.21 | -1.13 | -1.22 | -1.14 | -1.05 | -1.01 | -0.95 | -0.94 | -0.89 | -0.84 | -0.79 | -0.69 |
EPS (Diluted) | -0.48 | -0.58 | -0.63 | -0.89 | -0.94 | -1.06 | -1.21 | -1.13 | -1.22 | -1.14 | -1.05 | -1.01 | -0.95 | -0.94 | -0.89 | -0.84 | -0.79 | -0.69 |
EBITDA | -182.49M | -214.1M | -241.76M | -421.08M | -436.05M | -444.29M | -432.95M | -309.06M | -343.83M | -324.05M | -333.74M | -342.74M | -331.8M | -334M | -316.12M | -289.85M | -261.65M | -227.25M |
EBIT | -231.57M | -263.71M | -259.32M | -439.04M | -454.16M | -464.57M | -454.69M | -333.1M | -366.87M | -346.03M | -353.79M | -361.12M | -351.54M | -352.21M | -334.99M | -313.87M | -294.7M | -258.75M |
Depreciation & Amortization | 16.3M | 16.83M | 17.55M | 17.96M | 18.11M | 20.02M | 21.75M | 24.06M | 25.45M | 25.06M | 24.19M | 22.29M | 21.24M | 20M | 19.12M | 16.37M | 15.01M | 13.8M |